Cleared Traditional

K896245 - PLAK TRAC POWERED TOOTHBRUSH

K896245 is an FDA 510(k) clearance for PLAK TRAC POWERED TOOTHBRUSH, manufactured by Windmere Corp.. The device is a Class 1 Dental device with product code JEQ cleared through the Traditional 510(k) pathway after a 149-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 1990
Decision
149d
Days
Class 1
Risk

K896245 is an FDA 510(k) clearance for the PLAK TRAC POWERED TOOTHBRUSH. Classified as Toothbrush, Powered (product code JEQ), Class I - General Controls.

Submitted by Windmere Corp. (Miami Lakes, US). The FDA issued a Cleared decision on March 28, 1990 after a review of 149 days - within the typical 510(k) review window.

This device falls under the Dental FDA review panel, regulated under 21 CFR 872.6865 - the FDA dental device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Dental review framework, consistent with the majority of Class II 510(k) submissions.

View all Windmere Corp. devices

FDA 510(k) Submission Details - K896245

510(k) Number K896245 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 30, 1989
Decision Date March 28, 1990
Days to Decision 149 days
Submission Type Traditional
Review Panel Dental (DE)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
22d slower than avg
Panel avg: 127d · This submission: 149d
Pathway characteristics
Predicate-based equivalence.

JEQ Device Classification - Class 1, General Controls

Product Code JEQ Toothbrush, Powered
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 872.6865
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.